Sakurako Ohuchi

Sakurako Ohuchi

Auto-generated profile, based on publicly available information

Sakurako Ohuchi

Faculty of Pharmaceutical Sciences, Graduate School of Innovative Life Science, University of Toyama, 2630 Sugitani, Toyama, Japan

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
MJMeihua Jin
Meihua Jin
HSHiroki Shiwaku
Hiroki Shiwaku
HTHikari Tanaka
Hikari Tanaka
TOTakayuki Obita
Takayuki Obita
SOSakurako Ohuchi
Sakurako Ohuchi
HOhitoshi okazawa
hitoshi okazawa
Brain inflammation generally accompanies and accelerates neurodegeneration. Here we report a microglial mechanism in which polyglutamine binding protein 1 (PQBP1) senses extrinsic tau 3R/4R proteins by direct interaction and triggers an innate immune response by activating a cyclic GMP-AMP synthase (cGAS)-Stimulator of interferon genes (STING) pathway. Tamoxifen-inducible and microglia-specific depletion of PQBP1 in primary culture in vitro and mouse brain in vivo shows that PQBP1 is essential for sensing-tau to induce nuclear translocation of nuclear factor κB (NFκB), NFκB-dependent transcription of inflammation genes, brain inflammation in vivo, and eventually mouse cognitive impairment. Collectively, PQBP1 is an intracellular receptor in the cGAS-STING pathway not only for cDNA of human immunodeficiency virus (HIV) but also for the transmissible neurodegenerative disease protein tau. This study characterises a mechanism of brain inflammation that is common to virus infection and neurodegenerative disorders.